Explore the key genes and prognosis related to mitochondrial permeability transition driving necrosis gene in kidney renal clear cell carcinoma

Mitochondrial permeability transition (MPT)-driven necrosis is associated with kidney renal clear cell carcinoma (KIRC), but its role in prognosis remains unclear. This study develops a prognostic model for KIRC outcomes using MPT-driven necrosis-related genes (MPTDNRGs). Differentially expressed genes (DEGs) from TCGA-KIRC samples were analyzed and categorized based on MPTDNRGs scores. Three key genes—IL2RA, CD7, and CXCL13—were identified as significant prognostic markers and used to construct a risk model, validated through public datasets and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The risk score and age were the independent prognostic factors. A nomogram incorporating these factors demonstrated good clinical utility. The high-risk group was enriched in immune-related pathways, such as systemic lupus erythematosus, while the low-risk group showed enrichment in metabolism-related pathways, including butanoate metabolism. Significant differences in 25 immune cells were observed between the risk groups, with the high-risk group exhibiting higher TIDE scores, suggesting a greater likelihood of immune escape. Additionally, a ceRNA network revealed complex interactions, such as CXCL13-hsa-miR-670-5p-AL121985.1, and predicted 25 transcription factors for key MPTDNRGs. This study presents a novel prognostic model for KIRC based on three MPTDNRGs, offering valuable insights into KIRC prognosis and potential therapeutic targets.

• Publication year

  2025

• Venue

  Scientific Reports

• Publication date

  2025-11-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41598-025-24779-xPMID 41258419PMCID 12630615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD7 regulates the persistence of terminally exhausted CD8+ T cells during chronic infection.

  2025cited by this paper
• Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma

  2025cited by this paper
• Mitochondrial DNA signals driving immune responses: Why, How, Where?

  2025cited by this paper
• Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study

  2024cited by this paper
• KEGG: biological systems database as a model of the real world

  2024cited by this paper
• Mitochondrial DNA release via the mitochondrial permeability transition pore activates the cGAS-STING pathway, exacerbating inflammation in acute Kawasaki disease

  2024cited by this paper
• Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma

  2023cited by this paper
• Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies

  2023cited by this paper
• Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma

  2023cited by this paper
• Translation and Adaptation of the Adult Developmental Coordination Disorder/Dyspraxia Checklist (ADC) into Asian Uzbekistan

  2023cited by this paper
• Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma

  2023cited by this paper
• Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma

  2022cited by this paper
• Visualizing metabolomics data with R

  2022cited by this paper
• Oxidative Phosphorylation-Related Signature Participates in Cancer Development, and PTPRG Overexpression Suppresses the Cancer Progression in Clear Cell Renal Cell Carcinoma

  2022cited by this paper
• Immune Checkpoint Molecules and Glucose Metabolism in HIV-Induced T Cell Exhaustion

  2022cited by this paper
• Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

  2022cited by this paper
• The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation

  2022cited by this paper
• Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease

  2022cited by this paper
• ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2

  2022cited by this paper
• M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT

  2021cited by this paper
• Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma

  2021cited by this paper
• Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry

  2021cited by this paper
• Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

  2020cited by this paper
• Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis

  2020cited by this paper
• Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology

  2020cited by this paper
• CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal

  2020cited by this paper
• Toward understanding the origin and evolution of cellular organisms

  2019cited by this paper
• CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma

  2019cited by this paper
• Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma.

  2019cited by this paper
• Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

  2019cited by this paper
• Epidemiology of Renal Cell Carcinoma.

  2019cited by this paper
• Molecular and Metabolic Basis of Clear Cell Carcinoma of the Kidney.

  2018cited by this paper
• Renal cell carcinoma: a review of biology and pathophysiology

  2018cited by this paper
• Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

  2018cited by this paper
• Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.

  2018cited by this paper
• Prognostic factors and prognostic models for renal cell carcinoma: a literature review

  2018cited by this paper
• Bubble Treemaps for Uncertainty Visualization

  2018cited by this paper
• Maftools: efficient and comprehensive analysis of somatic variants in cancer

  2018cited by this paper
• Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training

  2017cited by this paper
• Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.

  2017cited by this paper
• plotROC: A Tool for Plotting ROC Curves.

  2017cited by this paper
• Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade

  2016cited by this paper
• Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma

  2015cited by this paper
• circlize implements and enhances circular visualization in R

  2014cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• GSVA: gene set variation analysis for microarray and RNA-Seq data

  2013cited by this paper
• Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States

  2013cited by this paper
• Integrated molecular analysis of clear-cell renal cell carcinoma

  2013cited by this paper
• Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function

  2012cited by this paper
• clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

  2012cited by this paper
• Mitochondria in cancer cells: what is so special about them?

  2008cited by this paper
• The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis

  2007cited by this paper
• Modulation of the Permeability Transition Pore by Inhibition of the Mitochondrial KATP Channel in Liver vs. Brain Mitochondria

  2007cited by this paper
• Coming up for air: HIF-1 and mitochondrial oxygen consumption.

  2006cited by this paper
• The role of the mitochondrial permeability transition in cell death.

  2006cited by this paper
• Mitochondria and aging: a role for the permeability transition?

  2004cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• KEGG: Kyoto Encyclopedia of Genes and Genomes

  2000cited by this paper

• No citing papers are available for this paper.